Fluoroazomycin arabinoside F-18

DB15134InvestigationalSmall molecule

Fluoroazomycin arabinoside F-18 is under investigation in clinical trial NCT03257150 (A Study of the Use of Irreversible Electroporation in Pancreatic Ductal Cancer).

Formula / weight: C₈H₁₀FN₃O₅ · 246.185 g/mol (avg)

Resolves to

Compound

UNIIUG7I3Y42PVCAS864084-85-5

Structure

InChIKeyLPZSRGRDVVGMMX-FJBGPTLJSA-NSMILESO[C@H]1[C@H](O)[C@H](O[C@@H]1C[18F])N1C=CN=C1[N+]([O-])=O

What you can answer from here — as of April 02, 2025

8Clinical trialsPhase, status and sponsor resolved per trial

Which companies are running trials of Fluoroazomycin arabinoside F-18, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account